Portland’s season took a hit before it started. Shaedon Sharpe tore the meniscus in his right knee during an offseason workout, had surgery, and will be reevaluated in six months.
Read that word carefully. Reevaluated, not returned. A six-month checkpoint puts the earliest realistic timeline somewhere around late February or early March, and that assumes nothing goes sideways in rehab.
Sharpe is 23. This is the second straight year a leg injury has taken a chunk of his season, after a stress fracture in his left fibula cost him significant time in 2025-26.
What Portland Loses
The Blazers lose their most explosive scorer. Sharpe averaged a career-high 20.8 points last season and was a big part of Portland reaching the playoffs for the first time since 2021.
He is also the player whose development most determined the ceiling of this roster. Portland spent years building around young talent and finally got a return on it. Losing Sharpe for most of a season stalls that momentum at the worst possible time.
The timing hurts twice over. Sharpe is entering the first season of the four-year, $90 million extension he signed ahead of last year. That deal looked like a bargain the day it was signed. It still might be. But the Blazers now have to wait a full year to find out whether they bought a rising star or a talented guard who cannot stay on the floor.
The Availability Problem
This is the part nobody in Portland wants to say out loud. Sharpe’s talent has never been in question. His availability has, and the fibula problem last season followed by this one makes that hard to wave off.
Explosive athletes who play above the rim take more wear than most, and there is no version of this where the Blazers do not have to build a plan that assumes Sharpe misses time. That changes how you construct a roster.
None of it is his fault. Meniscus tears in offseason workouts are bad luck more than anything. But bad luck that keeps arriving eventually becomes a planning problem.
What Happens Now
Portland’s guard rotation gets a lot of new opportunity, and the Blazers will need somebody to take it. Nobody on the roster replaces 20 points a game on their own, which means the scoring load spreads out and the offense leans harder on the frontcourt.
Realistically, Portland’s playoff odds just took a serious hit. Expecting a team that squeezed into the postseason to repeat without its leading scorer for most of the year is optimistic.
There is a version of this that works out. If Sharpe returns healthy in March and the Blazers are still in the play-in mix, he comes back fresh for the stretch run against teams that have played 70 games. That is a real advantage.
The more likely outcome is a development year. Portland gets long looks at its younger pieces, sorts out who belongs in the rotation, and holds a draft pick that suddenly matters a lot more than it did last week.
For a franchise that finally felt like it had turned the corner, that is a frustrating place to land. Sharpe’s return in the spring is the thing worth watching.
A longtime sports reporter, Carlos Garcia has written about some of the biggest and most notable athletic events of the last 5 years. He has been credentialed to cover MLS, NBA and MLB games all over the United States. His work has been published on Fox Sports, Bleacher Report, AOL and the Washington Post.
